Insulet (PODD)

• Market cap: $22B
• 1 day: 0.34%
• 5 days: -2.61%
• 1 month: 1.39%
• 3 months: 8.53%
• 6 months: 24.07%
• Year to date: 21.86%
• 1 year: 35.19%
• 5 years: 44.93%
• 10 years: 929.3%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 3,900